Bandingkan Harga & Kinerja Panorama Sentrawisata Tbk. (PANR) vs Tempo Scan Pacific Tbk. (TSPC)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Panorama Sentrawisata Tbk. dan Tempo Scan Pacific Tbk.: Panorama Sentrawisata Tbk. diperdagangkan di Rp418 (kapitalisasi pasar 579,98 M, volume 24 jam 195,5 rb), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.580 (kapitalisasi pasar 11,68 T, volume 24 jam 429,7 rb). Perbedaan utamanya: Tempo Scan Pacific Tbk. jauh lebih besar — sekitar 20,1× kapitalisasi pasar Panorama Sentrawisata Tbk., dan Tempo Scan Pacific Tbk. lebih aktif diperdagangkan (429,7 rb vs 195,5 rb). Mana yang lebih baik tergantung tujuan investasimu.
| PANR | TSPC | |
|---|---|---|
Kapitalisasi Pasar | 579,98 M | 11,68 T |
Volume | 195,5 rb | 429,7 rb |
Lot | 1,96 rb | 4,3 rb |
Perputaran | 80,78 jt | 1,11 M |
Harga Rata-rata | 413,21 | 2.591,65 |
Nilai Transaksi | 80,78 jt | 1,11 M |
Harga Ekuilibrium Indikatif | 422 | 2.580 |
Volume Ekuilibrium Indikatif | 30 | 100 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Panorama Sentrawisata Tbk.
PT. Panorama Sentrawisata Tbk (the Company) was established based on Notarial Deed No.71 dated July 22, 1995 and October 1995, of Sugiri Kadarisman, S.H., a public notary in Jakarta. The company has 4 divisions : 1. Inbound tours 2. Outbound Tours and Travel 3. Transportation tours 4. MICE (Meeting, Incentive, Conferences & Exhibition Organizer)
Selengkapnya di halaman PANR →Tentang Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Selengkapnya di halaman TSPC →
